Cardiac natriuretic peptides for diagnosis of covert atrial fibrillation after acute ischaemic stroke: a meta-analysis of diagnostic accuracy studies.
Kejia ZhangJoseph Kamtchum TatueneMingxi LiGlen C JicklingPublished in: Stroke and vascular neurology (2020)
NT-proBNP has a better performance than BNP for the diagnosis of covert AF after acute ischaemic stroke. Both biomarkers have low post-test probabilities and may not be used as a stand-alone decision-making tool for the diagnosis of covert AF in patients with acute ischaemic stroke. However, they may be useful for a screening strategy aiming to select patients for long-term monitoring of the heart rhythm.
Keyphrases
- atrial fibrillation
- ejection fraction
- end stage renal disease
- decision making
- heart failure
- left atrial
- catheter ablation
- oral anticoagulants
- chronic kidney disease
- newly diagnosed
- left atrial appendage
- direct oral anticoagulants
- left ventricular
- peritoneal dialysis
- percutaneous coronary intervention
- heart rate
- patient reported outcomes
- amino acid
- case control